Literature DB >> 3808575

Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.

G Ribéreau-Gayon, M L Jung, D Di Scala, J P Beck.   

Abstract

The bacterially fermented mistletoe preparation Iscador, used in cancer therapy for 30 years, and the recently prepared unfermented preparation, have been tested on rat hepatoma tissue culture (HTC) cells and human leukemia Molt 4 cells. As observed by phase-contrast microscopy, treatment of HTC cells with fermented or unfermented Iscador, at a concentration corresponding to 1 mg of fresh plant per milliliter culture, led to rapid lysis of cellular membranes. At a lower concentration, 0.1 mg/ml, unfermented Iscador led to the formation of polynucleated cells. On Molt 4 cells, fermented Iscador also produced cytolysis but after a longer time of action. Unfermented Iscador showed a much stronger cytotoxic effect on these cells than on HTC cells. Fermented Iscador was slightly more potent than unfermented Iscador in inhibiting the growth of HTC cells, but on Molt 4 cells fermented Iscador was less active than unfermented Iscador. DNA synthesis, measured by [3H]thymidine incorporation in HTC and Molt 4 cells, was inhibited by fermented and unfermented Iscador with the same type of differences of action as on cell growth. Fermented Iscador contained a low amount of lectins, approximately 100 ng/ml, while unfermented Iscador contained about 10 times more. A purified mistletoe lectin produced effects on HTC and Molt 4 cells similar to those of unfermented preparations. HTC cells were 100 times less sensitive to this lectin than Molt 4 cells. These results are discussed in relation to the known biological effects of lectins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3808575     DOI: 10.1159/000226418

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

Review 1.  Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-05       Impact factor: 8.262

2.  Effect of a mistletoe extract (Iscador QuFrF) on viability and migratory behavior of human peripheral CD4+ and CD8+ T lymphocytes in three-dimensional collagen lattices.

Authors:  G Nikolai; P Friedl; M Werner; B Niggemann; K S Zänker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

3.  Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells.

Authors:  Ling Ma; Swati Phalke; Caroline Stévigny; Florence Souard; David Vermijlen
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

4.  Untargeted metabolomics approach to discriminate mistletoe commercial products.

Authors:  Cécile Vanhaverbeke; David Touboul; Nicolas Elie; Martine Prévost; Cécile Meunier; Sylvie Michelland; Valérie Cunin; Ling Ma; David Vermijlen; Cédric Delporte; Stéphanie Pochet; Audrey Le Gouellec; Michel Sève; Pierre Van Antwerpen; Florence Souard
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

5.  Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.

Authors:  Chaitrali Saha; Mrinmoy Das; Emmanuel Stephen-Victor; Alain Friboulet; Jagadeesh Bayry; Srini V Kaveri
Journal:  Molecules       Date:  2016-07-14       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.